valine has been researched along with Heart Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashizume, A; Iijima, M; Ikeda, S; Katsuno, M; Kawagashira, Y; Koike, H; Nakamura, T; Nishi, R; Sobue, G | 1 |
| Chen, Z; Liu, Q; Qi, J; Shi, Y; Zhang, X | 1 |
| Alexander, A; Buxbaum, J; Fox, E; Kitzman, D; Koziol, J; Tagoe, C | 1 |
| Arya, DS; Bharti, S; Goyal, S; Sahoo, KC; Sharma, AK | 1 |
| Bozcali, E; Dedeoglu, DB; Karpuz, H; Karpuz, V; Suzer, O | 1 |
| Sheridan, C | 1 |
| Cohn, JN; Duprez, DA; Florea, ND; Jones, K | 1 |
| Batter, S; Casey, D; Febbo, PG; Giovannucci, E; Hennekens, CH; Kantoff, PW; Platz, EA; Stampfer, MJ | 1 |
| Coca, A; Giner, V | 1 |
| Corvol, P; Plouin, PF | 1 |
2 review(s) available for valine and Heart Diseases
| Article | Year |
|---|---|
[Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Heart Diseases; Heart Failure; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 1999 |
[Angiotensin II receptor blockers: current status and future prospects].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Diseases; Humans; Hypertension; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2002 |
2 trial(s) available for valine and Heart Diseases
| Article | Year |
|---|---|
Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV Pilot Study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Comorbidity; Coronary Artery Disease; Disease Progression; Double-Blind Method; Exercise Test; Female; Fluorescein Angiography; Health Status Indicators; Heart Diseases; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Pilot Projects; Predictive Value of Tests; Tetrazoles; Valine; Valsartan | 2007 |
The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Anticarcinogenic Agents; Aspirin; beta Carotene; Boston; Double-Blind Method; Heart Diseases; Humans; Isoenzymes; Leucine; Male; Middle Aged; Neoplasms; Polymorphism, Genetic; Prostatic Neoplasms; Risk Factors; Valine; White People | 1999 |
6 other study(ies) available for valine and Heart Diseases
| Article | Year |
|---|---|
Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Topics: 3-Iodobenzylguanidine; Aged; Amyloid Neuropathies, Familial; Autonomic Nervous System Diseases; Blood Pressure; Female; Heart Diseases; Humans; Male; Methionine; Microscopy, Electron, Transmission; Middle Aged; Mutation; Prealbumin; Radionuclide Imaging; Sural Nerve; Valine; Vasoconstriction | 2017 |
Transgenic proteins rich in valine or glycine are concerns for heart disease patients.
Topics: Glycine; Heart Diseases; Humans; Hydrogen Bonding; Plant Proteins, Dietary; Plants, Genetically Modified; Risk Assessment; Risk Factors; Valine | 2018 |
Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Black or African American; Female; Gene Frequency; Heart Diseases; Humans; Isoleucine; Kaplan-Meier Estimate; Male; Middle Aged; Mutation; Prealbumin; Ultrasonography; Valine | 2010 |
Valsartan, an angiotensin II receptor blocker, attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity.
Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiotonic Agents; Cardiotoxins; Heart Diseases; Heart Rate; Isoproterenol; Male; Oxidative Stress; Rats; Rats, Wistar; Tetrazoles; Valine; Valsartan | 2011 |
Cardioprotective effects of zofenopril, enalapril and valsartan against ischaemia/reperfusion injury as well as doxorubicin cardiotoxicity.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Doxorubicin; Enalapril; Heart Diseases; Hemodynamics; Humans; Male; Rats; Rats, Wistar; Reperfusion Injury; Tetrazoles; Valine; Valsartan | 2012 |
Calamitous HCV trial casts shadow over nucleoside drugs.
Topics: Antiviral Agents; Carbamates; Clinical Trials, Phase II as Topic; DNA-Directed RNA Polymerases; Drug Therapy, Combination; Heart Diseases; Humans; Imidazoles; Kidney Diseases; Nucleosides; Patient Selection; Pyrrolidines; Valine | 2012 |